Saturday 17 October 2026
Export SCNX’s income statement to Excel — free account
Scienture Holdings, Inc.
SCNX Healthcare Pharmaceutical Retailers
Scienture Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $431,600.00, up 216.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3,235.9%, EPS grew 85.4%, free cash flow fell 54.0% and total debt rose 831.4%, each against the same quarter a year earlier.
3.31
0.07
−2.07%
Follow SCNX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 2 | 4 | 2 | 4 | 4 | 5 | 5 | 3 |
P/E ratio |
0.00 | 56.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26,785.71 | 1,244.93 | 0.00 |
P/S ratio |
403.62 | 2,055.03 | 74.93 | 6.10 | 48.57 | 59.55 | 131.63 | 63.17 | 122.73 | 146.25 |
Altman Z-Score |
5.42 | 10.88 | (0.64) | 7.92 | 139.83 | 549.80 | 410.34 | 101.84 | 220.85 | 105.17 |
Altman Z″-Score (non-manufacturers) |
(0.88) | 0.96 | (15.57) | (22.60) | (9.45) | 8.44 | 2.14 | (9.71) | (38.05) | (124.35) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21,996.91 | 885.35 | 2,095.17 | 0.00 |
P/Operating CF |
(37.81) | (175.45) | (100.27) | 52.46 | (1,125.59) | (1,425.08) | (5,354.83) | 5,749.52 | 6,749.37 | (1,600.42) |
Beneish M-Score |
(3.19) | 19.51 | 14.21 | (3.87) | (4.34) | (1.19) | (1.72) | (2.47) | (1.24) | (13.36) |
P/B ratio |
2.79 | 6.46 | 188.39 | 182.25 | 127.39 | 117.48 | 236.43 | 286.56 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 157.77 | 128.21 | 286.70 | 2,039.22 | 0.00 | 0.00 |
EV/Sales |
394.23 | 2,057.92 | 75.10 | 6.06 | 48.38 | 59.24 | 131.29 | 63.10 | 122.82 | 146.28 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,435.73 | 0.00 | 744.16 | 0.00 |
EV/Operating CF |
(14.28) | (35.83) | (46.03) | (39.69) | (186.43) | (457.99) | 6,885.07 | 884.31 | 2,096.82 | (721.02) |
EV/FCF |
(11.99) | (30.38) | (48.63) | (39.70) | (183.81) | (450.36) | 21,939.40 | 884.31 | 2,096.82 | (721.02) |
Quick Ratio |
2.70 | 0.56 | 0.11 | 0.80 | 4.43 | 9.28 | 7.03 | 1.51 | 0.96 | 0.21 |
Current Ratio |
2.89 | 0.80 | 0.24 | 0.98 | 4.72 | 10.95 | 7.30 | 1.70 | 1.16 | 0.23 |
Net Debt/EBITDA |
0.17 | (0.05) | (0.01) | 0.15 | 0.36 | 2.20 | (11.63) | 0.29 | 1.00 | (0.86) |
Debt/Assets |
0.00% | 0.98% | 0.20% | 18.78% | 21.65% | 6.41% | 5.61% | 37.89% | 107.92% | 231.80% |
Debt/Equity |
0.00 | 0.01 | 0.05 | 2.03 | 0.33 | 0.07 | 0.08 | 1.00 | (2.14) | (0.68) |
Asset Turnover |
0.00 | 0.00 | 0.17 | 2.16 | 1.27 | 2.23 | 1.91 | 2.69 | 6.14 | 2.10 |
Operating CF/Net income |
0.32 | (1.57) | 0.12 | 0.45 | 0.48 | 0.87 | (0.50) | 30.38 | 0.59 | 0.18 |
Capex/Depreciation |
0.00 | (0.01) | 0.00 | 0.00 | (0.16) | (0.37) | (0.87) | (75.00) | 0.00 | 0.00 |
Interest Coverage |
(10.43) | (11.01) | (3.85) | (8.67) | (224.25) | (85.26) | 2.35 | (1.52) | 2.52 | (6.65) |
| (55.65%) | 22.77% | (4,031.09%) | (168.83%) | (85.40%) | (39.57%) | (11.41%) | 3.38% | (39.59%) | 626.51% | |
| (43.92%) | 15.45% | (219.71%) | (73.28%) | (68.33%) | (33.01%) | (7.29%) | 0.63% | 60.55% | (233.43%) | |
ROIC |
(41.95%) | (11.52%) | (484.54%) | 0.00% | (174.44%) | (46.25%) | 4.95% | (6.68%) | 144.75% | 0.00% |
Return on Tangible Assets |
(798.85%) | (572.37%) | 202.87% | (30,192.17%) | (149.87%) | (29.69%) | (8.23%) | 1.45% | 352.01% | 242.65% |
Average Days of Receivables |
618.45 | 11,088.68 | 327.77 | 22.43 | 36.13 | 40.35 | 38.88 | 41.30 | 39.78 | 43.99 |
Research and Development Expense of Revenue |
453.27% | 1,637.41% | 0.00% | 0.00% | 0.00% | 3.87% | 8.70% | 24.79% | 12.80% | 11.56% |
Selling, General and Administrative Expense of Revenue |
2,327.29% | 6,433.82% | 143.95% | 51.42% | 58.07% | 43.73% | 58.86% | 90.57% | 86.52% | 140.58% |
Intangible Assets out of Total Assets |
0.84 | 0.93 | 0.72 | 0.12 | 0.00 | 0.00 | 0.13 | 0.33 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1,477.99% | 3,384.99% | 21.08% | 3.25% | 3.94% | 10.88% | 3.79% | 4.43% | 9.56% | 5.95% |
Graham Net Nets |
(0.03) | (0.04) | (0.09) | (0.02) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 37.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | 0.00 | 24.95 |
Earnings Yield |
(21.65%) | 1.78% | (17.49%) | (5.56%) | (1.10%) | (0.24%) | (0.03%) | 0.00% | 0.08% | (0.82%) |
Free Cash Flow Yield |
(8.15%) | (3.30%) | (2.06%) | (2.50%) | (0.54%) | (0.22%) | 0.00% | 0.11% | 0.05% | (0.14%) |
Revenue per Share |
0.03 | 0.04 | 1.79 | 18.15 | 18.22 | 33.31 | 18.80 | 10.69 | 8.25 | 7.08 |
Operating CF per Share |
(0.87) | (4.23) | (2.91) | (2.77) | (4.73) | (4.31) | 0.36 | 0.76 | 0.48 | (1.44) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.04) | (0.07) | (0.21) | (0.04) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.87) | (4.23) | (2.91) | (2.77) | (4.77) | (4.38) | 0.15 | 0.72 | 0.48 | (1.44) |
Cash per Share |
0.43 | 0.09 | 0.00 | 1.94 | 5.75 | 11.52 | 7.26 | 2.43 | 0.52 | 0.04 |
Shareholders Equity per Share |
4.57 | 23.43 | 0.71 | 0.61 | 6.95 | 16.89 | 10.47 | 2.36 | (0.88) | (3.27) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.57 | 23.43 | 0.71 | 0.61 | 6.95 | 16.89 | 10.47 | 2.36 | (0.88) | (3.27) |
Free Cash Flow |
(13.38) | (14.28) | (2.23) | (1.56) | (2.59) | (2.25) | 0.06 | 0.26 | 0.17 | (0.50) |
Working Capital |
5.18 | (1.60) | (8.80) | (0.05) | 3.45 | 8.38 | 3.28 | 0.61 | 0.08 | (1.14) |
Capital Expenditures |
— | (0.01) | — | 0.00 | (0.02) | (0.04) | (0.08) | (0.01) | — | — |
Net Current Asset Value |
(6.14) | (19.48) | (9.24) | (1.27) | 2.38 | 8.11 | 2.37 | 0.08 | (0.32) | (1.15) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,791.73 | 0.00 | 911.22 | 0.00 |
Capex to Sales |
0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,812.15 | 0.00 | 910.51 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
235.67 | 55.19 | 139.97 | 2.99 | 1.41 | 0.63 | 0.54 | 0.01 | 0.00 | 0.00 |
Cash ROIC |
(17.43%) | (17.76%) | (391.97%) | (73.27%) | (31.80%) | (14.79%) | 0.81% | 10.10% | 31.89% | 143.04% |
Accounts Receivable Turnover |
0.18 | 0.05 | 1.47 | 12.74 | 6.89 | 12.76 | 12.13 | 10.18 | 9.48 | 7.59 |
Accounts Payable Turnover |
0.05 | 0.06 | 1.32 | 9.41 | 14.02 | 38.60 | 6.98 | 1.77 | 0.00 | 0.07 |
Inventory Turnover |
0.93 | 0.00 | 39.54 | 77.68 | 7.83 | 17.37 | 37.51 | 7.10 | — | 0.00 |
Average Days of Payables |
5,262.78 | 8,101.27 | 406.14 | 40.74 | 33.85 | 8.21 | 47.60 | 325.57 | 0.00 | 5,270.24 |
Days of Inventory on Hand |
778.13 | 0.00 | 0.28 | 5.05 | 4.00 | 40.22 | 8.08 | 65.03 | — | 0.00 |
Average Receivables |
2.44 | 2.69 | 0.93 | 0.80 | 1.44 | 1.34 | 0.61 | 0.38 | 0.31 | 0.33 |
Average Payables |
2.17 | 2.18 | 1.00 | 0.50 | 0.37 | 0.30 | 0.37 | 0.25 | 0.17 | 0.23 |
Average Inventory |
0.11 | — | 0.03 | 0.06 | 0.66 | 0.66 | 0.07 | 0.06 | — | — |
Average Assets |
94.52 | 58.69 | 8.12 | 4.74 | 7.78 | 7.68 | 3.90 | 1.42 | 0.48 | 1.18 |
Average Common Equity |
74.60 | 39.81 | 0.44 | 2.06 | 6.22 | 6.41 | 2.49 | 0.27 | (0.73) | (0.44) |
Columns are period end dates